Riximyo
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Riximyo, covering 2025-08-05 to 2025-08-05. Get the full timeline:
Most recent: EMA Authorised: Riximyo (rituximab) — Sandoz GmbH
1 regulatory and trial event tracked for Riximyo, covering 2025-08-05 to 2025-08-05. Get the full timeline:
Most recent: EMA Authorised: Riximyo (rituximab) — Sandoz GmbH